MediciNova Stock Forecast, Price & News

MediciNova (NASDAQ:MNOV) Frequently Asked Questions

Is MediciNova a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediciNova in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MediciNova stock.
View analyst ratings for MediciNova or view top-rated stocks.

How has MediciNova's stock been impacted by COVID-19 (Coronavirus)?

MediciNova's stock was trading at $3.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MNOV shares have decreased by 32.5% and is now trading at $2.22.
View which stocks have been most impacted by COVID-19.

Are investors shorting MediciNova?

MediciNova saw a decrease in short interest in December. As of December 15th, there was short interest totaling 1,890,000 shares, a decrease of 17.5% from the November 30th total of 2,290,000 shares. Based on an average trading volume of 496,600 shares, the days-to-cover ratio is currently 3.8 days. Approximately 4.1% of the company's stock are short sold.
View MediciNova's Short Interest.

When is MediciNova's next earnings date?

MediciNova is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for MediciNova.

How were MediciNova's earnings last quarter?

MediciNova, Inc. (NASDAQ:MNOV) released its quarterly earnings results on Friday, November, 12th. The biopharmaceutical company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.09) by $0.02. The biopharmaceutical company earned $0.04 million during the quarter.
View MediciNova's earnings history.

What price target have analysts set for MNOV?

2 brokerages have issued 12 month price objectives for MediciNova's stock. Their forecasts range from $15.00 to $15.00. On average, they expect MediciNova's stock price to reach $15.00 in the next year. This suggests a possible upside of 575.7% from the stock's current price.
View analysts' price targets for MediciNova or view top-rated stocks among Wall Street analysts.

Who are MediciNova's key executives?

MediciNova's management team includes the following people:

• Yuichi Iwaki, President, Chief Executive Officer & Director
• Douglas Paulin, Chief Financial Officer
• Federico Gaetani, Chief Scientific Officer
• Kazuko Matsuda, Director & Chief Medical Officer
• Geoffrey G. O'Brien, Vice President & Executive Officer

Who are some of MediciNova's key competitors?

Some companies that are related to MediciNova include OrganiGram (OGI), ORIC Pharmaceuticals (ORIC), Ocular Therapeutix (OCUL), Prelude Therapeutics (PRLD), DiaMedica Therapeutics (DMCAF), Rigel Pharmaceuticals (RIGL), CytoDyn (CYDY), PyroGenesis Canada (PYR), Vera Therapeutics (VERA), Aadi Bioscience (AADI), Affimed (AFMD), Veru (VERU), Pliant Therapeutics (PLRX), Theseus Pharmaceuticals (THRX) and Verona Pharma (VRNA).
View all of MNOV's competitors.

What other stocks do shareholders of MediciNova own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediciNova investors own include Dynavax Technologies (DVAX), VBI Vaccines (VBIV), OPKO Health (OPK), Iovance Biotherapeutics (IOVA), Novavax (NVAX), Rigel Pharmaceuticals (RIGL), Trevena (TRVN), Viking Therapeutics (VKTX), Aldeyra Therapeutics (ALDX) and CymaBay Therapeutics (CBAY).

What is MediciNova's stock symbol?

MediciNova trades on the NASDAQ under the ticker symbol "MNOV."

How do I buy shares of MediciNova?

Shares of MNOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MediciNova's stock price today?

One share of MNOV stock can currently be purchased for approximately $2.22.

How much money does MediciNova make?

MediciNova has a market capitalization of $108.88 million. The biopharmaceutical company earns $-13.85 million in net income (profit) each year or ($0.23) on an earnings per share basis.

How many employees does MediciNova have?

MediciNova employs 9 workers across the globe.

When was MediciNova founded?

MediciNova was founded in 2000.

What is MediciNova's official website?

The official website for MediciNova is medicinova.com.

Where are MediciNova's headquarters?

MediciNova is headquartered at 4275 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA, 92037.

How can I contact MediciNova?

MediciNova's mailing address is 4275 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA, 92037. The biopharmaceutical company can be reached via phone at (858) 373-1500, via email at [email protected], or via fax at 858-404-0048.